Andrew Wu

Andrew Wu, MSc., currently serves as an Associate Strategy Consultant at Triangle Insights Group by Mercalis, where responsibilities include leading client-facing strategy engagements in oncology and rare disease. Notable achievements encompass identifying a $500M+ commercial opportunity for an oncology asset, prioritizing over 10,000 assets for business development, and validating market adoption drivers through extensive primary research. With a strong background in molecular biology and scientific writing at BC Cancer, Andrew has conducted impactful research on therapeutic targets in chronic myeloid leukemia and engaged with stakeholders at international conferences. Previous consulting roles include life science consulting at Collective Acumen and project management at 180 Degrees Consulting, alongside significant research assistant positions at reputable institutions. Andrew holds a Master of Science in Interdisciplinary Oncology and a Bachelor of Science in Biology from the University of British Columbia.